Analyst consensus rating
Solid Biosciences Analyst Rating: Strong Buy
SLDB is rated Strong Buy by 12 analysts with a $17.83 target. As of 2026-08-26.
Direct answer
Solid Biosciences's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.83.
Forecast evidence checked August 26, 2026.
Get free Solid Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.89
- Average price target
- $17.83
- High price target
- $26.00
- Low price target
- $11.00
- Low target gap
- +11.2%
- Target upside
- +80.3%
- High target gap
- +162.9%
- Target range width
- 151.7%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Solid Biosciences?
Solid Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $17.83.
How far are Solid Biosciences's low and high targets from the recorded price?
The low target implies +11.2%, while the high target implies +162.9%.
How many analysts are included in Solid Biosciences's consensus?
The verified consensus includes 12 analysts.
How is Solid Biosciences's target upside or downside calculated?
The average target of $17.83 is divided by the recorded price of $9.89, then one is subtracted to produce +80.3%. This does not guarantee a future return.
When was Solid Biosciences's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.